94067 ⎘
Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
Sub-classes:PROCESS FOR PRODUCING PYRROLE COMPOUND
#2Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
#3Process for producing pyrrole compound
#4Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
#5Process for producing pyrrole compound
#6Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
#7Compositions for organ preservation
#85-aryl-1H-pyrrole-3-carbonitrile and a pharmaceutical product using the same
#9Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
#10Pyrrolo[2,3-d]pyrimidine compound or salt thereof
#11BIOSOURCED COMPOUND HAVING EPOXIDE FUNCTIONS, METHOD FOR THE SYNTHESIS OF SUCH A COMPOUND, AND USE THEREOF FOR PRODUCING EPOXY RESIN
#125-aryl-1H-pyrrole-3-carbonitrile and a pharmaceutical product using the same
#13Substituted phenylpyrrolecarboxamides with therapeutic activity in HIV
#14Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
#15Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
#16Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
#17ArylSulfonamide-based matrix metalloprotease inhibitors
#18Process for producing pyrrole compound
#19Arylsulfonamide based matrix metalloprotease inhibitors
#20Process for producing pyrrole compound
#21SUBSTITUTED PORPHYRINS
#22Arylsulfonamide-based matrix metalloprotease inhibitors
#23Biaryl carboxylic acid apoptosis promoters
#24Histamine H3-receptor ligands and their therapeutic applications
#25Apoptosis promoters
#26Cyclic sulfone containing retroviral protease inhibitors
#27Process for preparation of sulfamide derivatives
#28Methods of preparing retroviral proteases inhibitor intermediates
#29Method of preparing retroviral protease inhibitor intermediates